Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.

ABSTRACT:

SUBMITTER: Iacoboni G 

PROVIDER: S-EPMC9631549 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature